Aliso Viejo, California, and we have additional locations in the United States, Canada, United Kingdom, Germany, Japan, Australia and Brazil. How will you make an impact? The Lead Manufacturing Technician will be directly responsible for: Prepare components and build assemblies Ability to perform activities under a microscope Prepare bulk drug formulations Perform the following: Filing, capping, and crimping operations Packaging and labeling operations Sampling Visual inspections Real-time review of all executed documentation on the floor Oversee and assign daily production activities Ensure proper documentation (c GMP and GDP) Open/close work orders in Maximo and the enterprise resource
planning (ERP) system Oversee inventory on a daily basis in the ERP system Ability to address and resolve daily issues on the manufacturing floor Provide feedback and escalation to leadership Maintain production yield database Provide support for QMS including non-conformances (NCs), corrective and preventative actions (CAPAs), and change controls (CCs)) Additional tasks as required What will you do?
Maintain the operation schedule and allocate resources accordingly Oversee daily production activities Review all documentation and ensure completion following c GMP, QMS, and GDP guidelines. Use of Word, Excel and ERP to complete document reviews, training, and inventory Maintain
on the floor inventory for accuracy Revise documentation to ensure accuracy and compliance Communicate feedback to engineering on non-standard build requests, validation builds, clinical builds, etc.
How will you get here? High School Diploma Required 8+ years of related experience with high school diploma 6+ years of related experience with associate degree in science or engineering 4+ years of experience with bachelor's degree in science or engineering Demonstrates increased responsibility and leadership skills Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible. These are just a few of the terms our employees use to describe their experiences as a part of the Glaukos family.
Those may seem like big aspirations, but here at Glaukos, we recognize the deep significance and profound meaning that comes from knowing that we can make a meaningful difference by helping improve eyesight of people worldwide. And because we're a rapidly growing company with a dynamic, fast-paced culture, individual employees are empowered with more diverse and enriching challenges that might not be possible at a larger company, and more fulfillment in knowing every person and every task is directly tied to making a difference in the life of others.
We offer competitive salary (based on experience), bonus eligibility, medical/dental/vision, life insurance, stock options, 401(k) Employer Match, Employee Stock Purchase Program, generous time off & paid holidays as well as time-off to volunteer in the community, plus the opportunity to work for a company that is pioneering a new glaucoma treatment class! Moreover, Glaukos Corporation has been Certified as a Great Place to Work the last three years! Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, interaction including interactionual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.
ABOUT US Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and medical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Our company was the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure which revolutionized the treatment and management of glaucoma.
In 2012, we launched our first MIGS device-the i Stent®-in the United States, followed by our next-generation i Stent inject® device in September 2018 and i Stent inject® W in September 2020. In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and medical therapies for glaucoma, corneal health, and retinal diseases. Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol " GKOS" Our global headquarters is located in San Clemente, California with additional locations in Waltham and Burlington, Massachusetts.
Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employmentwithout regard to race, color, religion, interaction including interactionual orientation and genderidentity, national origin, disability, protected Veteran Status, or any othercharacteristic protected by applicable federal, state, or local law.
